Bacterial GTPases as druggable targets to tackle antimicrobial resistance

Bioorg Med Chem Lett. 2023 May 1:87:129276. doi: 10.1016/j.bmcl.2023.129276. Epub 2023 Apr 6.

Abstract

Small molecules as antibacterial agents have contributed immensely to the growth of modern medicine over the last several decades. However, the emergence of drug resistance among bacterial pathogens has undermined the effectiveness of the existing antibiotics. Thus, there is an exigency to address the antibiotic crisis by developing new antibacterial agents and identifying novel drug targets in bacteria. In this review, we summarize the importance of guanosine triphosphate hydrolyzing proteins (GTPases) as key agents for bacterial survival. We also discuss representative examples of small molecules that target bacterial GTPases as novel antibacterial agents, and highlight areas that are ripe for exploration. Given their vital roles in cell viability, virulence, and antibiotic resistance, bacterial GTPases are highly attractive antibacterial targets that will likely play a vital role in the fight against antimicrobial resistance.

Keywords: Antibiotic resistance; Bacteria; GTPases; Hydrolysis; Inhibitor.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Bacteria
  • Drug Resistance, Bacterial*
  • Virulence

Substances

  • Anti-Bacterial Agents